We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688297:SSEAvic (Chengdu) UAS Co., Ltd. Class A Analysis

Data as of 2026-05-29 - not real-time

CN¥44.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

AVIC (Chengdu)UAS is trading at CNY 44.4, well above its DCF‑derived fair value of CNY 19.1 and an astronomically high trailing PE of 341x versus an industry average of ~30x, indicating the stock is heavily overvalued. Revenue has surged 143% year‑on‑year, but gross and operating margins remain thin (10% and 1.8% respectively) and profitability is modest, with a profit margin of only 2.6% and ROE of 1.55%. The balance sheet is strong – cash of CNY 4.1 bn dwarfs debt of CNY 0.15 bn – yet the company’s dividend yield is sub‑0.5% and the payout ratio is effectively zero, raising questions about dividend sustainability.
Technical indicators show a bearish price trend: the price sits below the 20‑day (45.2) and 50‑day (47.9) SMAs, and while the MACD histogram has turned slightly positive, the MACD line remains negative. Volatility is high at nearly 38% over the past 30 days, and beta is slightly negative, suggesting limited correlation with broader market moves. In this context, the stock faces elevated short‑term risk despite its solid cash position and growth prospects in the UAV sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price remains above immediate support but below key moving averages
  • High valuation metrics (PE, price vs DCF) limit upside
  • Elevated volatility and bearish technical trend

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistent overvaluation relative to fundamentals
  • Thin profit margins despite strong revenue growth
  • Regulatory and sector headwinds in China’s defense industry

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust cash position and low debt provide financial flexibility
  • Strategic growth opportunity in the expanding UAV market
  • Potential price correction toward DCF fair value offers upside

Key Metrics & Analysis

Financial Health

Revenue Growth143.60%
Profit Margin2.64%
P/E Ratio341.5
ROE1.55%
ROA-0.02%
Debt/Equity2.57
P/B Ratio5.2
Op. Cash FlowCN¥258.3M
Free Cash FlowCN¥247.3M
Industry P/E30.0

Technical Analysis

TrendBearish
RSI44.6
SupportCN¥41.99
ResistanceCN¥47.95
MA 20CN¥45.21
MA 50CN¥47.90
MA 200CN¥49.87
MACDBullish
VolumeStable
Fear & Greed Index93.16

Valuation

Fair ValueCN¥19.07
GradeOvervalued
TypeGrowth
Dividend Yield0.46%

Risk Assessment

Beta-0.12
Volatility37.88%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.